{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:44:52Z","timestamp":1788536692952,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017542","name":"Beijing Hospital","doi-asserted-by":"publisher","award":["BJ-2022\\u2013139"],"award-info":[{"award-number":["BJ-2022\\u2013139"]}],"id":[{"id":"10.13039\/501100017542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.cca.2024.119950","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T17:13:09Z","timestamp":1724865189000},"page":"119950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Coagulation factors VIII and factors IX testing practices in China: Results of the 5-year external quality assessment program"],"prefix":"10.1016","volume":"565","author":[{"given":"Chengshan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongli","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.cca.2024.119950_b0005","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/jth.12672","article-title":"F.I.X. Subcommittee on Factor Viii, S. Rare Coagulation Disorders of the, T. Standardization Committee of the International Society on, Hemostasis, Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.cca.2024.119950_b0010","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Working Party on von Willebrand Disease, Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.cca.2024.119950_b0015","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/bjh.19385","article-title":"Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors' Organisation and the British Society for Haematology","volume":"204","author":"Platton","year":"2024","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.cca.2024.119950_b0025","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.3324\/haematol.2019.242735","article-title":"Kreuth V initiative: European consensus proposals for treatment of hemophilia using standard products, extended half-life coagulation factor concentrates and non-replacement therapies","volume":"105","author":"Peyvandi","year":"2020","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cca.2024.119950_b0030","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ijlh.13550","article-title":"International Council for Standardization in Haematology (ICSH) laboratory guidance for the verification of haemostasis analyser-reagent test systems. Part 2: Specialist tests and calibrated assays","volume":"43","author":"Gardiner","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"issue":"3 Suppl","key":"10.1016\/j.cca.2024.119950_b0035","first-page":"560","article-title":"Factor VIII (antihemophilic factor) assay results in the 1976 College of American Pathologists Survey Program","volume":"70","author":"Harms","year":"1978","journal-title":"Am. J. Clin. Pathol."},{"issue":"2 Suppl","key":"10.1016\/j.cca.2024.119950_b0040","first-page":"346","article-title":"Cap survey results for factor VIII assays (1977\u20131978)","volume":"72","author":"Kocoshis","year":"1979","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2024.119950_b0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0609.1980.tb01348.x","article-title":"Factor assay VIII and IX) results in the College of American Pathologists Survey Program (1976\u20131979)","volume":"37","author":"Triplett","year":"1980","journal-title":"Scand. J. Haematol. Suppl."},{"issue":"4 Suppl","key":"10.1016\/j.cca.2024.119950_b0050","first-page":"633","article-title":"Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980\u20131982)","volume":"80","author":"Christensen","year":"1983","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cca.2024.119950_b0055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-0609.1984.tb02772.x","article-title":"Factor VIII assay proficiency assessment: experience in the USA","volume":"41","author":"Maas","year":"1984","journal-title":"Scand. J. Haematol. Suppl."},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0060","first-page":"7","article-title":"Factor VIII assays Assessment of Variables","volume":"112","author":"Brandt","year":"1988","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"9","key":"10.1016\/j.cca.2024.119950_b0065","first-page":"908","article-title":"Factors affecting the performance of factor VIII coagulant activity assays results of proficiency surveys of the college of american pathologists","volume":"116","author":"Arkin","year":"1992","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"3","key":"10.1016\/j.cca.2024.119950_b0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2007-971811","article-title":"Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program","volume":"33","author":"Cunningham","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.cca.2024.119950_b0075","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1309\/AJCPMKP94CODILWS","article-title":"Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience","volume":"131","author":"Peerschke","year":"2009","journal-title":"Am. J. Clin. Pathol."},{"issue":"3","key":"10.1016\/j.cca.2024.119950_b0080","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/ijlh.12083","article-title":"Factor VII assay performance: an analysis of the North American Specialized Coagulation Laboratory Association proficiency testing results","volume":"35","author":"Zantek","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"issue":"7","key":"10.1016\/j.cca.2024.119950_b0085","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1055\/s-0033-1356573","article-title":"Problems and solutions in laboratory testing for hemophilia","volume":"39","author":"Favaloro","year":"2013","journal-title":"Semin. Thromb. Hemost."},{"issue":"Suppl 1","key":"10.1016\/j.cca.2024.119950_b0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ijlh.12359","article-title":"Quality of factor XI activity testing in North American Specialized Coagulation Laboratories","volume":"37","author":"Zantek","year":"2015","journal-title":"Int. J. Lab Hematol."},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0037-1614254","article-title":"A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants","volume":"79","author":"de Maistre","year":"1998","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.cca.2024.119950_b0100","first-page":"990","article-title":"Interference of rivaroxaban in one-stage and chromogenic factor VIII: C assays","volume":"106","author":"Tichelaar","year":"2011","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1309\/C8T8YNB4G3W45PRF","article-title":"Comparison of three methods for measuring factor VIII levels in plasma","volume":"120","author":"Chandler","year":"2003","journal-title":"Am. J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.cca.2024.119950_b0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jth.13215","article-title":"A critical appraisal of one-stage and chromogenic assays of factor VIII activity","volume":"14","author":"Peyvandi","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/IJPM.IJPM_900_19","article-title":"Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level","volume":"64","author":"Baig","year":"2021","journal-title":"Ind. J. Pathol. Microbiol."},{"issue":"6","key":"10.1016\/j.cca.2024.119950_b0120","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ijlh.12877","article-title":"Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B","volume":"40","author":"Adcock","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"issue":"8","key":"10.1016\/j.cca.2024.119950_b0125","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1515\/cclm-2022-1207","article-title":"Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands","volume":"61","author":"Hollestelle","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/cclm-2020-0741","article-title":"Study of total error specifications of lymphocyte subsets enumeration using China National EQAS data and Biological Variation Data Critical Appraisal Checklist (BIVAC)-compliant publications","volume":"59","author":"Li","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"issue":"6","key":"10.1016\/j.cca.2024.119950_b0135","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/hae.14177","article-title":"Effects of Emicizumab on APTT, FVIII assays and FVIII Inhibitor assays using different reagents: Results of a UK NEQAS proficiency testing exercise","volume":"26","author":"Lowe","year":"2020","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.cca.2024.119950_b0140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/bjh.16776","article-title":"British Society for Haematology, F. Thrombosis Task, Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis","volume":"191","author":"Baker","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.cca.2024.119950_b0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/hae.14562","article-title":"Advantages of external quality assessment-EQA programs","volume":"28","author":"Montalvao","year":"2022","journal-title":"Haemophilia"},{"key":"10.1016\/j.cca.2024.119950_b0150","doi-asserted-by":"crossref","unstructured":"A. Srivastava, E. Santagostino, A. Dougall, S. Kitchen, M. Sutherland, S.W. Pipe, M. Carcao, J. Mahlangu, M.V. Ragni, J. Windyga, A. Llinas, N.J. Goddard, R. Mohan, P.M. Poonnoose, B.M. Feldman, S.Z. Lewis, H.M. van den Berg, G.F. Pierce, W.F.H.G.f.t.M.o.H. panelists, a. co, WFH Guidelines for the Management of Hemophilia, 3rd edition, Haemophilia 26 Suppl 6 (2020) 1-158.","DOI":"10.1111\/hae.14046"},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ijlh.12004","article-title":"British Committee for Standards in, Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis","volume":"35","author":"Mackie","year":"2013","journal-title":"Int. J. Lab. Hematol."},{"issue":"1","key":"10.1016\/j.cca.2024.119950_b0160","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/hae.13656","article-title":"Accurate measurement of extended half-life and unmodified factor VIII low levels with one-stage FVIII assays is dependent on the matrix of calibration curves","volume":"25","author":"Van den Bossche","year":"2019","journal-title":"Haemophilia"},{"issue":"11","key":"10.1016\/j.cca.2024.119950_b0165","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.cca.2024.119950_b0170","doi-asserted-by":"crossref","first-page":"e12689","DOI":"10.1002\/rth2.12689","article-title":"Should multiple factor dilutions be performed for all patient coagulation factor assays? Let the debate begin!","volume":"6","author":"Favaloro","year":"2022","journal-title":"Philos. Phenomenol. Res.Pract Thromb Haemost"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124022034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124022034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T05:00:23Z","timestamp":1741064423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124022034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"alternative-id":["S0009898124022034"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.119950","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation factors VIII and factors IX testing practices in China: Results of the 5-year external quality assessment program","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.119950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119950"}}